-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Initiates Coverage On TuHURA Biosciences with Market Outperform Rating, Announces Price Target of $9

Benzinga·04/27/2026 13:49:18
Listen to the news
Citizens analyst Silvan Turkcan initiates coverage on TuHURA Biosciences (NASDAQ:HURA) with a Market Outperform rating and announces Price Target of $9.